0Suppliers
6Customers
3Debt Items
5Related Chains

Source-Backed Evidence Depth

CeriBell, Inc. (CBLL) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

10Total relationships
1Distinct source URLs
4High confidence
0.752Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

CeriBell, Inc. Suppliers

No suppliers on recordCeriBell, Inc. has not yet been matched to upstream suppliers in our database, or is still being processed.

CeriBell, Inc. Customers

TickerNameConfidenceEvidence
HRZN Horizon Technology Finance Corporation 72% Reciprocal relationship from HRZN graph: Reciprocal relationship from CBLL graph: Reciprocal relationship from HRZN graph: Reciprocal relationship from CBLL graph: vable inputs other than quoted pric…
HRZN Horizon Technology Finance Corporation 72% vable inputs other than quoted prices. 5. Balance Sheet Details Inventory Inventory consists of the following (in thousands): March 31, December 31, 2026 2025 Component materials $ 5,158 $ 4,985 Fini…
AI-TECHNOLOGIES AI-TECHNOLOGIES 62% cisions and/or guidance interpreting existing laws, could be significant and would increase our operating expenses (such as by imposing additional reporting obligations regarding our use of AI Techno…
BRAIN-STETHOSCOPE-INC BRAIN-STETHOSCOPE-INC 62% “hope,” or “continue” or the negative of these words or other similar terms or expressions that concern our expectations, strategy, plans, or intentions. Forward-looking statements contained in this …
DELAWARE-GENERAL-CORPORATION DELAWARE-GENERAL-CORPORATION 62% th prior or competing contractual obligations to assign inventions and intellectual property rights therein to another employer, to a former employer, or to another person or entity. Many of our curr…
NATUS-MEDICAL-INCORPORATED NATUS-MEDICAL-INCORPORATED 62% t cash used in operating activities during the three months ended March 31, 2025, consisted primarily of our net loss of $12.8 million, offset by non-cash charges of stock-based compensation of $2.3 …

CeriBell, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
CBLL-DEBT Debt stack $22.1M 90% Market cache reports total debt of $22.1M.
CBLL-DEBT-8503 Xbrl Convertible 90% xbrl convertible detail from xbrl 2024-12-31.
CBLL-DEBT-8502 Warrants outstanding: 0 90% xbrl warrant detail from xbrl 2025-12-31.

CeriBell, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for CeriBell, Inc..

CeriBell, Inc. Ownership

HolderNameConfidenceEvidence
CBLL-OWNER-FMR-LLC FMR LLC 90% 13F overlay lists FMR LLC as top holder; 122 tracked holders.

CeriBell, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
PTHS Pelthos Therapeutics Inc. 100.00 2
PDSB PDS Biotechnology Corporation 100.00 2
IMNN Imunon, Inc. 50.00 2
MRCC Monroe Capital Corporation 50.00 2
HRZN Horizon Technology Finance Corporation 38.88 1 ['customer']
🔐
CBLL
Unlock CBLL Supply Chain Data
Verified relationships include:
HRZNHorizon Technology Financ…Customer72%
HRZNHorizon Technology Financ…Customer72%
+6 more relationships locked
Subscribe — View plans →